306 related articles for article (PubMed ID: 17217924)
1. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Noda Y; Nabeshima T
Biol Psychiatry; 2007 Sep; 62(6):658-68. PubMed ID: 17217924
[TBL] [Abstract][Full Text] [Related]
2. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T
Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726
[TBL] [Abstract][Full Text] [Related]
3. Involvement of glial cell line-derived neurotrophic factor in inhibitory effects of a hydrophobic dipeptide Leu-Ile on morphine-induced sensitization and rewarding effects.
Niwa M; Nitta A; Shen L; Noda Y; Nabeshima T
Behav Brain Res; 2007 Apr; 179(1):167-71. PubMed ID: 17331595
[TBL] [Abstract][Full Text] [Related]
4. The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence.
Niwa M; Nitta A; Yamada K; Nabeshima T
J Pharmacol Sci; 2007 Jun; 104(2):116-21. PubMed ID: 17538232
[TBL] [Abstract][Full Text] [Related]
5. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.
Fujio M; Nakagawa T; Sekiya Y; Ozawa T; Suzuki Y; Minami M; Satoh M; Kaneko S
Eur J Neurosci; 2005 Dec; 22(11):2744-54. PubMed ID: 16324108
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model.
Wu Y; Na X; Zang Y; Cui Y; Xin W; Pang R; Zhou L; Wei X; Li Y; Liu X
Biochem Biophys Res Commun; 2014 Jul; 449(4):502-7. PubMed ID: 24845379
[TBL] [Abstract][Full Text] [Related]
8. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.
Han J; Xu Y; Yu CX; Shen J; Wei YM
Eur J Pharmacol; 2008 Oct; 594(1-3):125-31. PubMed ID: 18706407
[TBL] [Abstract][Full Text] [Related]
9. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
10. NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study.
Kao JH; Huang EY; Tao PL
Drug Alcohol Depend; 2011 Nov; 118(2-3):366-74. PubMed ID: 21601998
[TBL] [Abstract][Full Text] [Related]
11. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
12. [Candidate genes or compounds for therapeutic tools against methamphetamine and/or morphine-induced dependence].
Nitta A; Yamada Y; Nakajima A; Noda Y; Yamada K; Nabeshima T
Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():81P-83P. PubMed ID: 14727530
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice.
Shoblock JR; Maidment NT
Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992
[TBL] [Abstract][Full Text] [Related]
14. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice.
Nakagawa T; Fujio M; Ozawa T; Minami M; Satoh M
Behav Brain Res; 2005 Jan; 156(2):233-9. PubMed ID: 15582109
[TBL] [Abstract][Full Text] [Related]
15. An antisense oligodeoxynucleotide to the mu opioid receptor attenuates cocaine-induced behavioral sensitization and reward in mice.
Hummel M; Schroeder J; Liu-Chen LY; Cowan A; Unterwald EM
Neuroscience; 2006 Oct; 142(2):481-91. PubMed ID: 16893609
[TBL] [Abstract][Full Text] [Related]
16. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
[TBL] [Abstract][Full Text] [Related]
18. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
[TBL] [Abstract][Full Text] [Related]
19. Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice.
Walters CL; Godfrey M; Li X; Blendy JA
Brain Res; 2005 Jan; 1032(1-2):193-9. PubMed ID: 15680959
[TBL] [Abstract][Full Text] [Related]
20. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
